Diabetes and metabolism Archives - Page 2 of 8

Podcasts

Maintaining muscle mass & nutritional status while losing weight on GLP-1RAs

This presentation discuss the risk of nutritional deficits and loss of muscle mass associated with the use of GLP-1 receptor agonists and recommendations on how to reduce these risks.

Clinical Articles

Ten ways diabetes and dementia are linked

New research shows how blood sugar problems affect brain health and vice versa. Here are ten evidence-based insights into how the two conditions are related.

Videos

The role of GLP-1s in type 2 diabetes-related kidney disease

Discover the latest evidence behind semaglutide 1.0mg's recent CKD indication in T2D and its impact on everyday practice.

Podcasts

Obesity as a chronic disease: Rethinking assessment and escalation of care

Dr Melissa Beitner discusses how to approach obesity as a chronic disease, providing clear insights on assessment, treatment options, and the GP’s role in long-term patient support.

Videos

Cardiovascular benefits of GLP-1s – New evidence

Discover how semaglutide 2.4mg aligns with best practice cardiac care guidelines.

Videos

Tirzepatide Product Explainer – A new indication and data

In this Product Explainer, Endocrinologist Dr Ted Wu explains the comparative features of tirzepatide and its indications (6 mins).

Clinical Articles

New thresholds & screening criteria for gestational diabetes

What the changes mean for managing women who were diagnosed under previous cut-offs, and more key takeaways...

Podcasts

Continuous glucose monitoring for diabetes management in GP

Professor Gary Kilov explains how and why CGM works.

Clinical Articles

Chronic Wound Consumables Scheme finally here

A good step that doesn't go far enough

Expert/s: Healthed

Videos

Diabetes Specific Nutritional Formulas (DSNFs) demystified

In this Product Explainer, General Practitioner Dr Gary Deed explains the role of Diabetes Specific Nutritional Formulas (DSNFs) and addresses some myths and misconceptions (6 mins).

Videos

Reducing cardiovascular death with SGLT2 inhibitors – Important updates for GPs

Prof Sindone and Dr Wu discuss the importance of SGLT2 inhibitors and the ground-breaking evidence that has seen this class of drugs now PBS-listed.

Videos

Clinical Case: 36-year-old female with obesity

In this Quick Case Endocrinologist A/Prof Samantha Hocking presents the obesity management case of a 36-year-old female, describes treatment options, clinical outcomes, and provides some take home messages.

Diabetes and metabolism

Maintaining muscle mass & nutritional status while losing weight on GLP-1RAs

This presentation discuss the risk of nutritional deficits and loss of muscle mass associated with the use of GLP-1 receptor agonists and recommendations on how to reduce these risks.

Ten ways diabetes and dementia are linked

New research shows how blood sugar problems affect brain health and vice versa. Here are ten evidence-based insights into how the two conditions are related.

The role of GLP-1s in type 2 diabetes-related kidney disease

Discover the latest evidence behind semaglutide 1.0mg's recent CKD indication in T2D and its impact on everyday practice.

Obesity as a chronic disease: Rethinking assessment and escalation of care

Dr Melissa Beitner discusses how to approach obesity as a chronic disease, providing clear insights on assessment, treatment options, and the GP’s role in long-term patient support.

Cardiovascular benefits of GLP-1s – New evidence

Discover how semaglutide 2.4mg aligns with best practice cardiac care guidelines.

Tirzepatide Product Explainer – A new indication and data

In this Product Explainer, Endocrinologist Dr Ted Wu explains the comparative features of tirzepatide and its indications (6 mins).

New thresholds & screening criteria for gestational diabetes

What the changes mean for managing women who were diagnosed under previous cut-offs, and more key takeaways...

Continuous glucose monitoring for diabetes management in GP

Professor Gary Kilov explains how and why CGM works.

Chronic Wound Consumables Scheme finally here

A good step that doesn't go far enough

Diabetes Specific Nutritional Formulas (DSNFs) demystified

In this Product Explainer, General Practitioner Dr Gary Deed explains the role of Diabetes Specific Nutritional Formulas (DSNFs) and addresses some myths and misconceptions (6 mins).

Reducing cardiovascular death with SGLT2 inhibitors – Important updates for GPs

Prof Sindone and Dr Wu discuss the importance of SGLT2 inhibitors and the ground-breaking evidence that has seen this class of drugs now PBS-listed.

Clinical Case: 36-year-old female with obesity

In this Quick Case Endocrinologist A/Prof Samantha Hocking presents the obesity management case of a 36-year-old female, describes treatment options, clinical outcomes, and provides some take home messages.

Get the app

Site

Company

Connect

Legal

Healthed

Upcoming Healthed Webcast

Tune in for "Facial rashes case studies - Practical guide to assessment and management" lecture

Tuesday 9th June, 7pm - 9pm AEST

Speaker

Dr Philip Tong

Consultant Dermatologist; Founder, DermScreen, Dermatology Junction; Visiting Medical Officer, St Vincent’s Hospital Sydney

What does it mean when a facial red rash does not respond to topical steroids and gets worse with the treatment? Dermatologist Dr Philip Tong presents a series of cases with this scenario.

Diabetes and metabolism

This presentation discuss the risk of nutritional deficits and loss of muscle mass associated with the use of GLP-1 receptor agonists and recommendations on how to reduce these risks.

New research shows how blood sugar problems affect brain health and vice versa. Here are ten evidence-based insights into how the two conditions are related.

Discover the latest evidence behind semaglutide 1.0mg's recent CKD indication in T2D and its impact on everyday practice.

Dr Melissa Beitner discusses how to approach obesity as a chronic disease, providing clear insights on assessment, treatment options, and the GP’s role in long-term patient support.

Discover how semaglutide 2.4mg aligns with best practice cardiac care guidelines.

In this Product Explainer, Endocrinologist Dr Ted Wu explains the comparative features of tirzepatide and its indications (6 mins).

What the changes mean for managing women who were diagnosed under previous cut-offs, and more key takeaways...

Professor Gary Kilov explains how and why CGM works.

A good step that doesn't go far enough

In this Product Explainer, General Practitioner Dr Gary Deed explains the role of Diabetes Specific Nutritional Formulas (DSNFs) and addresses some myths and misconceptions (6 mins).

Prof Sindone and Dr Wu discuss the importance of SGLT2 inhibitors and the ground-breaking evidence that has seen this class of drugs now PBS-listed.

In this Quick Case Endocrinologist A/Prof Samantha Hocking presents the obesity management case of a 36-year-old female, describes treatment options, clinical outcomes, and provides some take home messages.

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Extra Details

Healthed

Upcoming Healthed Webcast

Tune in for "Facial rashes case studies - Practical guide to assessment and management" lecture

Tuesday 9th June, 7pm - 9pm AEST

Speaker

Dr Philip Tong

Consultant Dermatologist; Founder, DermScreen, Dermatology Junction; Visiting Medical Officer, St Vincent’s Hospital Sydney

What does it mean when a facial red rash does not respond to topical steroids and gets worse with the treatment? Dermatologist Dr Philip Tong presents a series of cases with this scenario.